ERAPERMED, JOINT TRANSNATIONAL CALL 2020 - ESTHER RODRÍGUEZ, OPE ISCIII GA-ID: 779282 - EULAC PERMED
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
ERAPerMed, Joint Transnational Call 2020
Esther Rodríguez, OPE ISCIII
GA-ID: 779282
National Institute of Health Carlos III (ISCIII), Montevideo, 9-13 December 2019
ERAPerMed – Content 1. About ERA PerMed 2. Joint Transnational Calls: figures & facts 3. JTC 2020: calendar & budget 4. Steps of a Call
ERA PerMed – ERA NET on Personalised Medicine
➢ Time frame: 1 December 2017 – 30 November 2022
➢ Consortium: 32 funding organisations from 23 countries (AT, BE, CA, DE, DK, ES, EE, FI,
FR, HR, HU, IE, IL, IT, LV, LU, NL, NO, PL, RO, SE, SI, TR)
The biggest ERA Net in health
19 EU countries
3 associated countries (H2020) : IL, NO, TR
1 third country: CA
23 countries 5 regions
32 partners ES (Navarre, Catalane)
IT (Lombardy)
DE (Saxony)
Coordination: CA (Québec)
Instituto de Salud Carlos III
(ISCIII), SPAIN
Joint Transnational Calls (JTCs)
1 Call cofunded by the EC➔ 2018
3 Calls non-cofunded : 2019, 2020, 2021
ERA PerMed – ERA NET on Personalised Medicine
➢ Time frame: 1 December 2017 – 30 November 2022
➢ Consortium: 32 funding organisations from 23 countries (AT, BE, CA, DE, DK, ES, EE, FI,
FR, HR, HU, IE, IL, IT, LV, LU, NL, NO, PL, RO, SE, SI, TR)
The biggest ERA Net in health
19 EU countries
3 associated countries (H2020) : IL, NO, TR
1 third country: CA
ERA PerMed and ICPerMed
are closely connected.
23 countries 5 regions ➔ ICPerMed Action Plan and SRIA are
32 partners ES (Navarre, Catalane) consulted during the preparation of
IT (Lombardy) the calls
DE (Saxony)
Coordination: CA (Québec) https://www.
Instituto de Salud Carlos III icpermed.eu/
(ISCIII), SPAIN
Joint Transnational Calls (JTCs) www.erapermed.eu
1 Call cofunded by the EC➔ 2018
3 Calls non-cofunded : 2019, 2020, 2021 (decision to go adopted on 12/09/2019)
Source: ERA PerMed ANR, FranceERAPerMed – EU co-financiada JTC 2018
19 países EU
3 países asociados (a Horizon 2020):
Turquía, Noruega, Israel
1 tercer país: Canadá
31 Socios 23 Países 5 regiones (Navarra, Cataluña,
Lombardia, Sajonia y Québec)
Joint Call Secretariat (JCS)
Instituto de Salud Carlos III (ISCIII)
ESPAÑA
25 proyectos financiados
Presupuesto: 28 M € aprox.ERAPerMed – EU co-financiada JTC2018
200
180
176 M€
159
160
140
120
100
80
59 M€
60 50
40 28,3M€
25
20
0
Pre-propuestas Propuestas Financiados
completas
Nº solicitudes Presupuesto solicitadoERAPerMed –JTC no cofinanciada 2019
17 UE estados miembros
3 países asociados (a Horizon 2020):
Turquía, Noruega, Israel
2 terceros países: Canadá y Egipto
31 Socios 22 Países 6 regiones (Sajonia, Quebec, Lombardia,
Navarra, Cataluña y Toscana
Call Secretariat (JCS): 1 ONG (FCAECC)
Agence National de la Recherche (ANR)
FRANCE
Presupuesto estimado:
31 M €
Convocatoria en dos fasesERAPerMed –no cofinanciada JTC2019
250
216 M€
200
196
150
100
56 65 M€
50
22 24,6 M€
0
Pre-propuestas Propuestas Financiados
completas
Nº solicitudes Presupuesto solicitadoERAPerMed –no cofinanciada JTC2019
Áreas médicas en pre-propuestas
80 75
70
60
N° of proposals
50
40
29
30
20 13 14
10 10 9
10 5 4 3 5 5 3 3
2
0
OTRAS: piel, transfusión, rehabilitación, fertilidad, músculosERAPerMed –JTC no cofinanciada 2020
17 UE estados miembros
2 países asociados (a Horizon 2020):
Noruega, Israel
3 terceros países: Canadá, Egipto y Panamá
32 Socios 23 Países 6 regiones (Sajonia, Québec, Lombardia,
Navarra, Cataluña y Toscana
1 ONG (FCAECC)
Joint Call Secretariat (JCS):
German Aerospace Center (DLR)
ALEMANIA Presupuesto estimado
23 M €
PRE-ANNOUNCEMENT JTC 2020
http://www.erapermed.eu/category/news/Calendario estimado: ▪ Lanzamiento de la convocatoria: Diciembre 2019 ▪ Envío de la pre-propuesta: Marzo 2020 ▪ Envío de la full proposal: Junio 2020 ▪ Inicio de los proyectos financiados: Primer trimestre 2021
ERAPerMed – non EU co-funded JTC 2020
17 EU countries
3 associated countries (to Horizon 2020):
Turkey, Norway, Israel
3 third countries: Canada, Egypt, Panama
34 Partners 23 Countries 6 regions (Saxony, Wallonia, Lombardy,
Navarra ,Cataluña and Tuscany)
Call Secretariat (JCS) 1 charity: AECC
German Aerospace Center (DLR)
GERMANY Countries´ ex ante Budget
23 M € approx.
Two step procedure
Launch: December 2019
Timeline: Submission deadline for Pre-proposals: March 2020
Submission deadline for invited Full-proposals: June 2020
PRE-ANNOUNCEMENT JTC 2020 ALREADY ONLINE
http://www.erapermed.eu/category/news/ERAPerMed – non EU co-funded JTC 2020
Scope of the call
TOPIC: “PERSONALISED MEDICINE – PRE-/CLINICAL RESEARCH, BIG
DATA AND ICT, IMPLEMENTATION AND USER’S PERSPECTIVE”
Each project proposal MUST address at least one module of
Research Area 3 and at least one module of Research Area 1 or 2.Partnering Tool https://partnering.pt-dlr.de/ICPerMed
• Application done by each given
• Proposal by Coordinator participant (coordinator or
Reception of Reception de
• (received by the Call partner) research group to its
Secretariat) Proposals Solicitudes given Regional/national funding
organization
• Central Eligibility
• Selection of evaluators International Nacional/
• National/Regional Eligibility
• Remote and face-to-face Phase(s) Regional Phase
phace(s)
• Committed funds
Rules Ranking list Available funds • Possible national/ regional
increments
Selection of Projects to
be funded
National/ Steps of an
Regional Funding
process ERA-NET Call
Follow up:
• National/Regional
• InternationalInternational Eligibility (central) Criteria • Each consortium must involve at least 3 partners eligible for funding. (From a participating national/regional FO). • At least 3 different countries. • Maximum two participants per country. • Project coordinator must be eligible to be funded. • The maximum number of partners per project is 6 (7 if underrepresented) • No more than two partners from the same country. • No more than one partner with its own funding is allowed. * Each FO has its own national/regional eligibility criteria
International Eligibility (central) Criteria
FURTHER REQUIREMENTS
• Type of eligible organisation (variable);
Academia or research institutes; Clinical/public health sector;
(Industry) Private partners, e.g. SMEs. Patient organisations.
(depends upon the given FO)
• The proposal must comply with the topic of the call.
• Each partner represented by a single (PI).
• Comply with the formats required in the application
documents/online tool.
Full-proposal
Number of partners in the Pre-proposal
(only by inclusion of one underrepresented country)
proposal
3 4 5 6 7
Maximum number of partners
0 1 1 1 1
with own funding
Maximum number of partners
1 ERAPerMed
2 2 Convocatoria
2 2019 2
per countrySteps for International Submission st 1 Phase (Pre-proposal) • Register in the corresponding online tool (Coordinator)
Steps for International Submission st 1 Phase (Pre-proposal) Important. Obtain and read all relevant documents: Central: Call Text, Participant's Guidelines, Pre-proposal Form, Templates required by the Secretariat (DMP, Exploratory Clinical Studies). National/regional; e.g. pre-eligibility forms.
Steps for International Submission st 1 Phase (Pre-proposal) • To be submitted only by Coordinator and in English. • Comply with the required formats in each document to be submitted; DIN-A4, Calibri 11, a single space, maximum number of pages per section, in PDF, maximum 8 megabites. • Comply with deadlines, in date and time (the server closes). • Comply with the requirements regional/national funding agency where you are eligible. • Make sure you provide an appropriate contact email.
Steps for International Submission
nd
2 Phase (Full Proposal)
.
• Obtain and read all relevant documents: Full proposal
template.
• To be submitted only by Coordinator and in English.
• Comply required formats.
• Comply with online limits in date and time.
• Be aware of the rebuttal ("reply period"). Information sent
only to the Coordinator's email.Evaluation Process • 2-stage calls (pre-proposal and full proposal). • Remote and face-to-face peer review evaluation panels. • At least 3 evaluations per project. • Evaluation criteria: Excellence, Impact and Implementation of the project. • Panel between 50 and 90 experts for remote evaluation and between 15 and 25 evaluators for face-to-face evaluation. • Score from 0 to 5 per criterion (Total from 0 to 15 points). • There may be a threshold for criteria and/or a threshold for total score.
Evaluation steps Reception of Pre- Phase 1
Proposals
Pre-Proposal
National/ Regional
Eligibility Assignment of
Central eligibility
evaluators
Remote evaluation
• Preliminary Ranking list
Face-to-Face
• PRP
evaluation
2 to 3 times
Rules Ranking list available funds
Selection of consortia
• CSC Meeting invited to Submit a Full Coordinators are informed
ProposalEvaluation steps Reception of Full Phase 2
Proposals
Full Proposal
National/ Regional
Eligibility Assignment of
Central eligibility
evaluators
Remote evaluation
• Evaluators’ reports
• Preliminary Ranking list
• Optional for participants Rebuttal period
• PRP Face-to-Face evaluation
• Committed funds
Rules Available
Final Ranking List • Possible national/
funds regional increments
Selection of Projects to be
• CSC Meeting Coordinators are informed
FundedPARTICIPATION ADAVANTAGES As Funding Organization (FO): • Strength the international position of the given FO. • Enhance the networking and quality of their research teams. • Reduce health R&D cost by aligning expenses with other countries/regions (avoiding double funding). • Middle and long term run socio-economic impacts by improving national/regional health service and/or new employment lines linked to enhancement of the health sector industry. As Researcher: • Receiving funding for their research. • Strength the networking and international position. • Knowledge/technology transfer. • Helps/ encourage researchers to become entrepreneurs.
Contact:
Cristina Nieto, ERA PerMed Coordinator, ISCIII, mnieto@isciii.es
Mauricio Garcia-Franco, PhD mauriciog@isciii.es
COORDINATION UNITYou can also read
